Skip to content

Comparison of corticosteroid with botulinum toxin in treatment of chronic calcaneal spur

Clinical trial comparison of ultrasound guided local injection of botulinum toxin type A with corticosteroid in treatment of chronic plantar fasciitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190428043404N1
Enrollment
40
Registered
2019-12-25
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plantar fascial fibromatosis. Plantar fascial fibromatosis

Interventions

Intervention 1: Intervention group: will receive ultrasound guided localized injection of 150 unit botulinum toxin type A in the foot intrinsic muscles. Intervention 2: Control group:will receive ultr

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: history of plantar fasciitis,patients suffering from heel pain with a VAS more than 4 months for at leate two month whose history physical exam and sonography confirmed plantar fasciitis

Exclusion criteria

Exclusion criteria: History of direct trauma other causes of heel pain( fracture,tumor,infection,nerve entrapement) systemic inflammatory or soft tissue disease disk herniation with S1 radiculopathy poor controlled diabetes history of gout association with other causes of foot pain(severe osteoarthritis,morton neuroma,matatarsalgia) surgery or injection in fascia since 6 month ago coagulopathy pregnancy hypersensitivity to corticosteriod or botulinum toxin or lidocain antibody against botulinum toxin any treatment for the condition since 4 weeks ago anti inflammatory drugs,physiotherapy,splint, iontophoresis, phonophoresis and shock wave in the last 3 month

Design outcomes

Primary

MeasureTime frame
Pain intensity at the standing position. Timepoint: All the outcomes were evaluated at the baseline visit,1 month and 3 months after the intervention. Method of measurement: Visual analog scale.

Secondary

MeasureTime frame
Early morning pain,pain on joint movement,daily activities,climbing stairs and exercise tolerance. Timepoint: All the outcomes were evaluated at the baseline visit,1 month and 3 months after the intervention. Method of measurement: Visual analog scale.we also assess the ability to perform daily activities,climbing stairs and exercise tolerance with FAAM questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSasan Sadeghi Nik

Iran University of Medical Sciences

sasansadeghinik444@gmail.com+98 21 8214 1229

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026